Literature DB >> 2914296

Effects of sodium ascorbate (vitamin C) and 2-methyl-1,4-naphthoquinone (vitamin K3) treatment on human tumor cell growth in vitro. I. Synergism of combined vitamin C and K3 action.

V Noto1, H S Taper, Y H Jiang, J Janssens, J Bonte, W De Loecker.   

Abstract

The effects of sodium ascorbate (vitamin C) and 2-methyl-1,4-naphthoquinone (vitamin K3) administered separately or in combination on the in vitro cultured human neoplastic cell lines MCF-7 (breast carcinoma), KB (oral epidermoid carcinoma), and AN3-CA (endometrial adenocarcinoma) have been examined. When given separately, vitamin C or K3 had a growth inhibiting action only at high concentrations (5.10(3) mumol/1 and 10(5) nmol/l, respectively). Combined administration of both vitamins demonstrated a synergistic inhibition of cell growth at 10 to 50 times lower concentrations. At this level separately given vitamins are not toxic. The sensitivity to this treatment was somewhat different in the three cell lines, being slightly higher for KB line. This tumor cell growth inhibitory effect was completely suppressed by the addition of catalase to the culture medium containing vitamins C and K3, suggesting an excessive production of hydrogen peroxide as being implied in mechanisms responsible for the above-mentioned effects.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2914296     DOI: 10.1002/1097-0142(19890301)63:5<901::aid-cncr2820630518>3.0.co;2-g

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  17 in total

1.  Antioxidant intake and risk of endometrial cancer: results from the Nurses' Health Study.

Authors:  Xiaohui Cui; Bernard Rosner; Walter C Willett; Susan E Hankinson
Journal:  Int J Cancer       Date:  2011-03-01       Impact factor: 7.396

Review 2.  Specificity of the suppression of metastatic phenotype by tyrosine and phenylalanine restriction.

Authors:  C A Elstad; G G Meadows; R M Abdallah
Journal:  Clin Exp Metastasis       Date:  1990 Sep-Oct       Impact factor: 5.150

3.  Serum markers variation consistent with autoschizis induced by ascorbic acid-menadione in patients with prostate cancer.

Authors:  Eduardo Lasalvia-Prisco; Silvia Cucchi; Jesús Vázquez; Eduardo Lasalvia-Galante; Wilson Golomar; William Gordon
Journal:  Med Oncol       Date:  2003       Impact factor: 3.064

4.  Vitamin C protects HL60 and U266 cells from arsenic toxicity.

Authors:  Nicos Karasavvas; Juan M Cárcamo; George Stratis; David W Golde
Journal:  Blood       Date:  2005-01-27       Impact factor: 22.113

5.  Mitochondria, Energy and Cancer: The Relationship with Ascorbic Acid.

Authors:  Michael J González; Glorivee Rosario-Pérez; Angélica M Guzmán; Jorge R Miranda-Massari; Jorge Duconge; Julio Lavergne; Nadia Fernandez; Norma Ortiz; Ana Quintero; Nina Mikirova; Neil H Riordan; Carlos M Ricart
Journal:  J Orthomol Med       Date:  2010

6.  The Electroporation as a Tool for Studying the Role of Plasma Membrane in the Mechanism of Cytotoxicity of Bisphosphonates and Menadione.

Authors:  Mantas Šilkūnas; Rita Saulė; Danutė Batiuškaitė; Gintautas Saulis
Journal:  J Membr Biol       Date:  2016-04-04       Impact factor: 1.843

7.  Cytotoxicity of ascorbate, lipoic acid, and other antioxidants in hollow fibre in vitro tumours.

Authors:  J J Casciari; N H Riordan; T L Schmidt; X L Meng; J A Jackson; H D Riordan
Journal:  Br J Cancer       Date:  2001-06-01       Impact factor: 7.640

Review 8.  Vitamins and Melanoma.

Authors:  Irene Russo; Francesca Caroppo; Mauro Alaibac
Journal:  Cancers (Basel)       Date:  2015-07-24       Impact factor: 6.639

9.  The Combination of Vitamin K3 and Vitamin C Has Synergic Activity against Forms of Trypanosoma cruzi through a Redox Imbalance Process.

Authors:  Vânia Cristina Desoti; Danielle Lazarin-Bidóia; Fabianne Martins Ribeiro; Solange Cardoso Martins; Jean Henrique da Silva Rodrigues; Tania Ueda-Nakamura; Celso Vataru Nakamura; Valdecir Farias Ximenes; Sueli de Oliveira Silva
Journal:  PLoS One       Date:  2015-12-07       Impact factor: 3.240

10.  2-Bromo-1,4-naphthoquinone: a potentially improved substitute of menadione in Apatone™ therapy.

Authors:  F S Graciani; V F Ximenes
Journal:  Braz J Med Biol Res       Date:  2012-05-17       Impact factor: 2.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.